EconPapers    
Economics at your fingertips  
 

Performance of Procalcitonin and Reactive Protein-C in the Diagnosis of Early Neonatal Infection At the C.H.U of Brazzaville

Jeanne Gambomi Kibah, franck Arnaud Kinsangou Moukobolo, Koumou Fylla Onanga, Rod Ibara-Okadandé, Nanikaly Moyen, Etienne Moukoundjimobe and Gaston Bowassa Ekouya
Additional contact information
Jeanne Gambomi Kibah: Faculty of Health Sciences, Marien Ngouabi University, Brazzaville, Congo. 2Biochemistry Department, CHU, Brazzaville, Congo
franck Arnaud Kinsangou Moukobolo: Faculty of Health Sciences, Marien Ngouabi University, Brazzaville, Congo. 2Biochemistry Department, CHU, Brazzaville, Congo
Koumou Fylla Onanga: Faculty of Health Sciences, Marien Ngouabi University, Brazzaville, Congo. 2Biochemistry Department, CHU, Brazzaville, Congo
Rod Ibara-Okadandé: Faculty of Health Sciences, Marien Ngouabi University, Brazzaville, Congo. 2Biochemistry Department, CHU, Brazzaville, Congo
Nanikaly Moyen: Faculty of Health Sciences, Marien Ngouabi University, Brazzaville, Congo.3Service de Bactériologie-Immunologie-Virologie CHU, Brazzaville Congo
Etienne Moukoundjimobe: Faculty of Health Sciences, Marien Ngouabi University, Brazzaville, Congo.4Lomo University of research, Kinshasa, DRC
Gaston Bowassa Ekouya: Faculty of Health Sciences, Marien Ngouabi University, Brazzaville, Congo.5Neonatology Department, Centre Hospitalier Universitaire, Brazzaville, Congo

International Journal of Latest Technology in Engineering, Management & Applied Science, 2025, vol. 14, issue 5, 1018-1021

Abstract: The aim of this study was to evaluate the performance of procalcitonin and C-reactive protein in the diagnosis of early neonatal infection at Brazzaville University Hospital. This is a cross-sectional analytical study of 43 patients followed up in the Neonatology Department of the Brazzaville University Hospital Centre between July and November 2021. Procalcitonin, C-reactive protein and blood cultures were positive in 90.7%, 37.2% and 60% of cases respectively. The p-value was significant for procalcitonin (p = 0.001). The performance criteria for the biomarkers studied evolved in the opposite direction. However, the sensitivities of procalcitonin and C-reactive protein were 100% and 42.3% respectively, and the specificities of these biomarkers were 70.6% and 23.5% respectively. Procalcitonin cannot be used as the sole marker of neonatal infection ; it must always be combined with C-reactive protein.

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.ijltemas.in/DigitalLibrary/Vol.14Issue5/1018-1021.pdf (application/pdf)
https://www.ijltemas.in/papers/volume-14-issue-5/1018-1021.html (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bjb:journl:v:14:y:2025:i:5:p:1018-1021

Access Statistics for this article

International Journal of Latest Technology in Engineering, Management & Applied Science is currently edited by Dr. Pawan Verma

More articles in International Journal of Latest Technology in Engineering, Management & Applied Science from International Journal of Latest Technology in Engineering, Management & Applied Science (IJLTEMAS)
Bibliographic data for series maintained by Dr. Pawan Verma ().

 
Page updated 2025-07-04
Handle: RePEc:bjb:journl:v:14:y:2025:i:5:p:1018-1021